News & Perspective

Oct 19, 2018

Oct 19, 2018

ASP Scan (Weekly) for Oct 19, 2018

Undetected MDR-TB in South Africa
Carbapenem prescribing algorithm
Rapid susceptibility tests
AMR surveillance in South Korea
Biomarkers and sepsis management
C difficile on hospital bed sheets
Colistin resistance diagnostics
Dearth of point-of-care tests
New-antibiotic distribution

Aug 28, 2009

Aug 28, 2009

WHO cites severe H1N1 cases as southern outbreaks wane

(CIDRAP News) – Novel H1N1 influenza outbreaks are starting to wane in the southern hemisphere, and while most cases are still mild, clinicians are reporting some severe cases of viral pneumonia in young, previously healthy people, the World Health Organization (WHO) said today.

Jul 07, 2009

Jul 07, 2009

WHO to ask countries to ease novel H1N1 testing

(CIDRAP News) – The World Health Organization (WHO) said today it will soon advise most countries to ease the volume of testing for novel H1N1 influenza and said testing related to recent oseltamivir-resistant cases has so far turned up no additional cases.

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»